Related Experiment Videos

Glomerular changes in normo- and microalbuminuric patients with long-standing insulin-dependent diabetes mellitus

P Fioretto1, M Mauer

  • 1Department of Internal Medicine, University of Padova, Italy.

Advances in Nephrology From the Necker Hospital
|January 1, 1997
PubMed

Insights

Microalbuminuria (MA) in long-standing insulin-dependent diabetes mellitus (IDDM) indicates advanced kidney lesions. Early detection and intervention are crucial for preventing diabetic nephropathy (DN) progression and end-stage renal disease (ESRD).

Area of Science:

  • Nephrology
  • Diabetology
  • Pathology

Background:

  • Patients with long-standing insulin-dependent diabetes mellitus (IDDM) exhibit diverse renal structures, even without significant albuminuria.
  • Renal lesions in normalbuminuric IDDM patients can range from normal to advanced, overlapping with those in patients with microalbuminuria (MA) and overt diabetic nephropathy (DN).

Purpose of the Study:

  • To investigate the spectrum of renal structural changes in normalbuminuric and microalbuminuric patients with long-standing IDDM.
  • To understand the relationship between albumin excretion rate (AER), glomerular filtration rate (GFR), hypertension, and renal pathology in IDDM.
  • To clarify the clinical utility and limitations of MA as a marker for DN progression.

Main Methods:

  • Histopathological examination of renal biopsies from IDDM patients with varying albuminuria levels.
  • Correlation of structural findings with clinical parameters such as GFR, blood pressure, and AER.
  • Analysis of glomerular basement membrane (GBM) and mesangial expansion in relation to AER.

Main Results:

  • Normalbuminuric patients can have renal lesions similar to those with MA or overt DN.
  • Low GFR and hypertension are associated with more advanced lesions in both normalbuminuric and microalbuminuric patients.
  • Increasing AER correlates with GBM and mesangial expansion, suggesting accelerated glomerular damage.
  • MA identifies patients at increased risk for DN progression, but its predictive precision is limited.

Conclusions:

  • MA is a valuable but not perfectly precise indicator of DN risk in IDDM.
  • The presence of MA signifies established DN lesions, necessitating close monitoring.
  • Therapies reducing MA may potentially slow progression to end-stage renal disease (ESRD), but GFR preservation must be demonstrated.

Related Concept Videos